222 results
424B2
SAVA
Cassava Sciences Inc
3 Jan 24
Prospectus for primary offering
4:22pm
Securities, LLC
U.S. Federal Income Tax Consequences:
You should carefully read the section entitled “Certain U.S. Federal Income Tax Consequences … ” on page S-20 of this prospectus supplement, and consult your tax advisor on tax treatment of the Warrants.
S-6
RISK FACTORS
An investment in our
8-A12B
EX-4.1
b7z30zch
3 Jan 24
Registration of securities on exchange
4:18pm
8-K
EX-4.1
kppkh
3 Jan 24
Entry into a Material Definitive Agreement
9:10am
8-A12G
EX-4.1
knrurf6iigjbp
2 Jan 24
Registration of securities
9:10am
8-K
EX-99.2
m4pt5wfbrli
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
EX-1.1
6jra6xwr ye0crc7wo
1 May 23
Entry into a Material Definitive Agreement
5:26pm
424B5
5kzipr 70otxonisb8is
1 May 23
Prospectus supplement for primary offering
5:26pm
S-3ASR
4bmda15z
1 May 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
qu2jq4uu6os ms
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
424B5
iq28yr tcbn3sg7t
21 Nov 22
Prospectus supplement for primary offering
8:00am